Canadian Cancer Trials Group Bulletins


American Society of Hematology Annual Meeting

Several Canadian Cancer Trials Group-related abstracts, including one reporting primary results of Canadian Cancer Trials Group LY.12 -- A Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Compared to Dexamethasone, Cytarabine, and Cisplatin plus/minus Rituximab as Salvage Chemotherapy for Patients with Relapsed or Refractory Aggressive Histology Non-Hodgkin'sLymphoma Prior to Autologous Stem Cell Transplant and Followed by Maintenance Rituximab versus Observation -- will be presented at the 55th American Society of Hematology Annual Meeting and Exposition being held December 7-10, 2013 in New Orleans.

You can view the complete listing of abstracts, as well as dates and location using this link ...